Nebulizers Market Analysis Report 2021 to 2022
Nebulizers Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 815.88 Million |
Market Size by 2031 | US$ 1315.57 Million |
Global CAGR (2023 - 2031) | 6.2% |
Historical Data | 2021-2023 |
Forecast period | 2023-2031 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Industry Developments and Future Opportunities:
As per company press releases, a few initiatives taken by key players operating in the global nebulizers market are listed below:
- In December 2021, Cipla Limited introduced an initiative to improve access to nebulization therapy for managing acute asthma in India's rural primary healthcare centers with its vast presence throughout the care continuum and a broad range of drug-device combinations and treatments.
- In March 2021, PARI Pharma GmbH launched its LAMIRA Nebulizer System, which has been authorized to deliver ARIKAYCE (amikacin liposome inhalation suspension) in Japan. This system uses advanced aerosol delivery systems based on eFlow Technology and features a customized medication reservoir that can hold a full dose of 8.4 ml.
- In March 2021, OMRON Healthcare, Inc. and the Asthma and Allergy Foundation of America (AAFA) collaborated to provide medical-grade nebulizers to support AAFA's advocacy and initiatives to spread awareness that aids the most vulnerable members of the asthma community.
Competitive Landscape and Key Companies:
OMRON Healthcare, Inc.; Koninklijke Philips N.V.; PARI GmbH; Vectura Group Ltd; Drive DeVilbiss International; Briggs Healthcare; GF Health Products, Inc.; GE Healthcare; Agilent Technologies, Inc.; Terumo Corporation; and Trudell Medical International are among the prominent companies profiled in nebulizers market report. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.